189 related articles for article (PubMed ID: 33595252)
41. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
Parker WH; Pritts EA; Olive DL
Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
[TBL] [Abstract][Full Text] [Related]
42. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation.
Ton R; Kilic GS; Phelps JY
J Minim Invasive Gynecol; 2015; 22(4):564-72. PubMed ID: 25623369
[TBL] [Abstract][Full Text] [Related]
43. Power morcellation in a specimen bag.
Cholkeri-Singh A; Miller CE
J Minim Invasive Gynecol; 2015 Feb; 22(2):160. PubMed ID: 25460317
[TBL] [Abstract][Full Text] [Related]
44. Power morcellators: a review of current practice and assessment of risk.
Senapati S; Tu FF; Magrina JF
Am J Obstet Gynecol; 2015 Jan; 212(1):18-23. PubMed ID: 25072737
[TBL] [Abstract][Full Text] [Related]
45. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe?
Hinchcliff EM; Cohen SL
Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837
[TBL] [Abstract][Full Text] [Related]
46. Low-Grade Endometrial Stromal Sarcoma Diagnosed 8 Years After Hysterectomy With Morcellation.
Sanneh A; Murdock T; Wethington SL; Fader AN; Xing D; Beavis AL
Obstet Gynecol; 2020 Aug; 136(2):365-368. PubMed ID: 32649495
[TBL] [Abstract][Full Text] [Related]
47. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
48. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
[TBL] [Abstract][Full Text] [Related]
49. Tissue Extraction Techniques for Leiomyomas and Uteri During Minimally Invasive Surgery.
Siedhoff MT; Cohen SL
Obstet Gynecol; 2017 Dec; 130(6):1251-1260. PubMed ID: 29112659
[TBL] [Abstract][Full Text] [Related]
50. The Medical Device Applied to Uterine Fibroids Morcellation: Analysis of Critical Biological Issues and Drawbacks from A Medical-Legal Prospective.
Mynbaev OA; Sparic R; Stark M; Malvasi A; Marinelli E; Zaami S; Tinelli A
Curr Pharm Des; 2020; 26(3):318-325. PubMed ID: 32013843
[TBL] [Abstract][Full Text] [Related]
51. Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018.
Rousseau M; Morel A; Dechoux S; Bouet PE; Catala L; Lefebvre Lacoeuille C; Descamps P; Legendre G
J Gynecol Obstet Hum Reprod; 2018 Oct; 47(8):341-349. PubMed ID: 29879489
[TBL] [Abstract][Full Text] [Related]
52. Contained Morcellation of Very Large Uterus.
Gil-Gimeno A; Laberge PY; Lemyre M; Gorak E; Maheux-Lacroix S
J Obstet Gynaecol Can; 2020 Jun; 42(6):802. PubMed ID: 32171503
[TBL] [Abstract][Full Text] [Related]
53. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
54. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
55. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
[TBL] [Abstract][Full Text] [Related]
56. Parasitic myomas may be more common than we think.
Parker W
BJOG; 2016 Jan; 123(1):76. PubMed ID: 26335152
[No Abstract] [Full Text] [Related]
57. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
58. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
[TBL] [Abstract][Full Text] [Related]
59. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
[TBL] [Abstract][Full Text] [Related]
60. Morcellation of occulted sarcomas during laparoscopic myomectomy and hysterectomy for patients with large fibroid uterus.
Tinelli A; Farghaly SA
Minerva Ginecol; 2018 Feb; 70(1):84-88. PubMed ID: 28975775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
